Misodel™ Vaginal Insert

Misodel (to be called the Misopess™ vaginal insert outside the U.S.) uses the same vaginal delivery system as Cervidil/Propess, but with a different active ingredient: misoprostol. Misoprostol, a synthetic PGE1 analogue, is approved as a cytoprotective agent for use with non-steroidal anti-inflammatory drugs, but is frequently used “off-label” for cervical ripening. Misoprostol has activity on both the cervix and the uterus and may serve both to ripen the cervix and augment labor. As such, Misodel may function as a one-step labor induction agent.

CPSI has licensed rights to Misodel to Hyundai Pharmaceuticals in Korea and to BMP Sunstone in China. The Company is currently looking for licensing partners in other parts of the world.